Key Financial Data Of Group

OncoTherapy Science, Inc. - Filing #7714893

Concept 2018-04-01 to
2018-12-31
2018-10-01 to
2018-12-31
As at
2018-12-31
2017-04-01 to
2018-03-31
As at
2018-03-31
2017-04-01 to
2017-12-31
As at
2017-12-31
2017-10-01 to
2017-12-31
Key financial data of group
Business results of group
Ordinary profit (loss)
-2,152,706,000 JPY
-2,977,177,000 JPY
-2,215,476,000 JPY
Profit (loss) attributable to owners of parent
-1,894,527,000 JPY
-2,851,092,000 JPY
-2,146,749,000 JPY
Comprehensive income
-2,129,148,000 JPY
-2,927,183,000 JPY
-2,169,376,000 JPY
Net assets
5,424,534,000 JPY
7,579,839,000 JPY
8,337,646,000 JPY
Total assets
5,771,057,000 JPY
8,021,524,000 JPY
8,848,248,000 JPY
Basic earnings (loss) per share
-12.89
-2.40
-19.39
-14.60
-5.30
Diluted earnings per share
Equity-to-asset ratio
0.881 xbrli:pure
0.870 xbrli:pure
0.868 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.